Beyond Medical Technologies Closes First Tranche of Convertible Note Financing for $1.68 Million and Announces Rebranding to Rep

  • Vancouver, British Columbia--(Newsfile Corp. - June 4, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the closing of the first tranche of its non-brokered private placement (the "Financing") for aggregate gross proceeds of CAD $1,680,000 (the equivalent of USD $1,200,000 based on an agreed exchange rate of 1.40:1) from the issuance of senior secured non-interest bearing convertible notes ("Notes"). The Notes carry the following terms: Convertible into common shares of the Company at the option of the holder at a conversion price of CAD $0.41 or 70% of the lowest issuance price of any equity securities issued by the Company (including the conversion price of any convertible instruments) subsequent to the date hereof and prior to the maturity date, whichever is lower, subject to compliance with the applicable rules and policies of the Canadian Securities Exchange.